ParagonRx® Case Studies

Re-invigorating Growth of a Mature Brand

Accelerating Growth of a Recently Launched Brand

Avoiding Premature Product Withdrawal

Re-invigorating Growth of a Mature Brand

A cardiovascular product was being utilized in less than 10% of the diagnosed population, despite clear evidence from multiple clinical trials that the product was highly effective.

In-depth assessment of the clinician barriers to adoption revealed that the drug was being underutilized because it was too complex to be practical. The drug required periodic blood monitoring, special patient education, management of potential drug interactions, dietary restrictions, and variable dosing schedules.

A system and tools were created to help physicians and their staffs use the drug with greater consistency and ease. The result was an increase in drug utilization to 40% of the diagnosed population, along with a nine-fold increase in sales.

Accelerating Growth of a Recently Launched Brand

Avoiding Premature Product Withdrawal

Search paragonrx.com:

powered by: Google

Join Our Newsletter

Keep up to date with events and news pertaining to pharmaceutical risk management and Process of Care®.

E-mail

Name

    Subscribe

    Unsubscribe


Privacy Statement: ParagonRx® will NOT sell, distribute, rent or otherwise intentionally share any information you provide to us with any third party without your consent.

home  |  about us  |  services  |  case studies  |  why ParagonRx  |  library  |  contact

© 2003-2006 ParagonRx, LLC. All Rights Reserved.